Trials / Completed
CompletedNCT06887010
A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants
A Study to Assess the Effect of Food on ABBV-101 Pharmacokinetics When Administered as an Oral ABBV-101 Tablet Formulation in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the effect of food (high fat) on oral ABBV-101 and how ABBV-101 moves through the body in healthy adult participants
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABBV-101 | Oral: Tablet |
Timeline
- Start date
- 2025-03-25
- Primary completion
- 2025-09-16
- Completion
- 2025-09-16
- First posted
- 2025-03-20
- Last updated
- 2025-10-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06887010. Inclusion in this directory is not an endorsement.